CAS: 2156634-62-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Befovacimab REF: TM-T76921CAS: 2156634-62-5 | - - - | To inquire | Tue 15 Oct 24 | |
Befovacimab REF: 3D-CLA1584CAS: 2156634-62-5 | - - - | To inquire | Thu 24 Oct 24 |
Befovacimab
CAS:2156634-62-5
Befovacimab, a human IgG2 antibody, targets TFPI for hemophilia A/B research.
Color and Shape:
Solid
Ref: TM-T76921
5mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Befovacimab
CAS:2156634-62-5
Human monoclonal antibody targeting tissue factor pathway inhibitor (TFPI); non-replacement therapy for haemophilia A/B patients
Ref: 3D-CLA1584
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 24 Oct 2024